| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in QURE over the last quarter tilts toward selling: insiders offloaded a net 19,875 shares worth roughly $557K.
Classified under Biotechnology (Health Care sector), QURE's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 133.2K | $6.19M | - | |
| Other | 124.8K | $5.79M | - | |
| CFO | 63.9K | $2.97M | - | |
| Dir | 53.3K | $2.47M | - | |
| Dir | 39.7K | $1.85M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2018 | Cantor Maria E | SVP, Investor Relations &Comm | Sell | 5,864 | $20.13 | $118,028.25 | -6.4% | |
| Jun 29, 2017 | Petry Harald | Chief Scientific Officer | Sale+OE | 49,300 | $6.02 | $296,567.99 | -100% | |
| Jun 27, 2017 | Petry Harald | Chief Scientific Officer | Sale+OE | 65,930 | $6.01 | $396,199.38 | -100% | |
| Mar 21, 2017 | Petry Harald | Chief Scientific Officer | Sale+OE | 25,422 | $6.03 | $153,289.58 | -100% |